Lindus Health

Thrilled to be a part of ARIA's Safeguarded AI program—a groundbreaking initiative to develop safer, more reliable AI in critical job sectors—to improve processes around clinical trial design! We're building AI with mathematically proven safety guarantees that researchers can rely on to inform decision-making during the trial design process. This means faster setup, lower costs, and accurate AI outputs to ultimately protect patients, improve retention, and accelerate study timelines. Our involvement in the Safeguarded AI program is a direct reflection of our dedication to revolutionizing clinical trial management and execution, ultimately accelerating the delivery of treatments to those who need them most.” Read now: https://lnkd.in/evQB3qxD #AI #healthcareinnovation #clinicaltrials #clinicalresearch #cro #clinicaltrialdesign #clinicaloperations

Women remain significantly underrepresented in clinical research—even after policies enacted in the 1990s to encourage their participation—resulting in crucial gaps in our understanding of conditions that uniquely or disproportionately affect them. In her recent article published in Femtech World, Dr Anita Phung discusses this ongoing imbalance and its consequences, as well as ways researchers can even the playing field to develop medical interventions that are effective for both men and women. Read her full article: https://lnkd.in/eaJAqM3t #womenshealth #inclusioninresearch #clinicalresearch #healthcareinnovation #womenshealthresearch #cro

We’re thrilled to announce a project that has been in the works for a while in the decentralized space! James Lind first proved the concept of clinical trials by testing different scurvy remedies with sailors on large ships. We’re going to show that you don’t need a large ship! All you need is a bunch of small one person boats and a good mobile data connection. Starting tomorrow, each member of the Lindus health team will be embarking on a months long journey on one person sailboats with various scurvy remedies. We’re each taking an iPad loaded with our trial platform, Citrus™, to record results. We’re also taking waterproof iPad cases so we don’t have to worry about getting our records wet as James Lind did. Wish us luck! (the control arm will need it) #aprilfools #clinicaltrials #clinicalresearch #cro

Pleased to be a part of the #Sifted100 leaderboard again – this time at #4! This award amplifies our mission to eliminate the traditional bottlenecks of clinical trial execution with tech-forward, patient-centric approaches. A big thank-you to our incredible team for helping us get here, and we’re honored to be named among the many other startups here! #clinicaltrials #clinicalresearch #cro #healthcareinnovation #AI #healthtech

Black adults face 20% higher rates of severe mental health issues like MDD, with significant barriers to care. Our groundbreaking trial with Sooma Medical's transcranial Direct Current Stimulation (tDCS) device for major depressive disorder (MDD) aims to change this landscape. Dr. John Twelves explains our deliberate efforts to recruit participants that reflect the real-world MDD population, such as Black Americans and other underserved groups, in his latest feature in BlackDoctor.org: https://lnkd.in/eTXMknpx #MDD #depression #diversityandinclusion #clinicaltrialrecruitment #clinicaltrials

ME/CFS patients experience extreme fatigue and diminished cognitive function, making it hard to partake in their normal daily activities, let alone clinical research. That’s why in our ReMEdi trial with Tiefenbacher Group, we pulled out all the stops to make it as patient-centric as possible, including: 🍊Digital advertising to make this groundbreaking research more accessible to patients 🍊A streamlined screening and enrollment process facilitated by our own eClinical technology, Citrus™ 🍊Fully virtual participation, allowing patients to submit all study data through Citrus™ from the comfort of their own homes Want to learn more about how we put patients in the center of our processes? DM us! #clinicalresearch #MECFS #clinicaltrials #cro

Most SaaS can be powerful, flexible, or simple—but it can’t be all three. Amiel Kollek likes to call this the “SaaS trilemma”, which is especially true for clinical trial software. At Lindus Health, we’re using AI to break the trilemma in our proprietary, customizable eClinical platform, Citrus™. By leveraging AI as a context-aware interface, we’re able to build Citrus™ to have power, flexibility, AND simplicity. Read Amiel’s new blog to learn more: https://lnkd.in/evm77SiB #AI #artificialintelligence #SaaS #clinicaltrials #EDC #clinicalresearchtech #cro

Our webinar, “Elevating Women’s Health With Evidence Generation,” is now available on-demand! Our panel of #womenshealth research experts, Dr Michelle Griffin (MFG Consulting), Lucy Jones (Oviva), Danielle Perro (Natural Cycles°) and Zara Liew (Lindus Health), draw from their personal experiences to share: ✨The significance generating evidence in women’s health ✨How to build a go-to-market strategy for your product(s) that aligns with your company goals ✨Important considerations for conducting clinical trials and RWE studies in women’s health Watch now: https://lnkd.in/erSZsPnC #womenshealthresearch #femtech #healthcareinnovation #startup #clinicaltrials #RWE #evidencegeneration #clinicalresearch

We’re excited to partner with Sooma Medical on their pivotal clinical trial for their innovative neuromodulation device aimed at treating major depressive disorder (MDD)! With depression affecting millions worldwide, this trial marks a crucial step toward expanding safe, effective, and accessible treatment options for those who haven’t seen success with the traditional standard of care. This trial will see participants in their real-world environments by leveraging our virtual site services, digital advertising recruitment tactics, and our home-grown eClinical technology, Citrus™, to manage all data collection and trial activities. Learn more: https://lnkd.in/eYmxzAKs #MDD #depression #clinicaltrials #depressionresearch #medicaldeviceresearch #medtech

Lindus Health and Tiefenbacher Group have joined forces in launching a groundbreaking Phase 2 clinical trial for ME/CFS! ME/CFS patients make up approximately 1% of the population and experience extreme fatigue, impaired cognitive function, and other symptoms that interrupt activities of daily living. There is no known cause or cure for this condition. Through digital advertising, wearable health devices, our proprietary eClinical technology (Citrus™), and more, we’re leveraging our virtual trial capabilities to recruit and observe patients in their real-world environments. Together, we aim to develop a better understanding of ME/CFS through patient-centered research and innovation. Read our announcement: https://lnkd.in/eNbQ3xuB #mecfs #mecfsresearch #chronicdiseases #healthcareinnovation